Potential Role of TNF-a in the Pathogenesis of Insulin Resistance and Type 2 Diabetes
By D. Moller. 2000
663 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/534c0d4df7a11d6afb29eb2d08c60144ccac5aab
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Federica Zatterale
- Jamal Naderi
- M. Longo
- G. A. Raciti
- Antonella Desiderio
- C. Miele
- F. Beguinot
- P. Lund
Citations in the corpus
- Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes (2020, background): “In spite of valuable effects in mice, a human clinical trial showed that antiTNF-α therapy leads to no improvements in insulin sensitivity in patients with T2D (Ofei et al., 1996; Moller, 2000; Paquot et al., 2000).”
- High-Fat Diet: Bacteria Interactions Promote Intestinal Inflammation Which Precedes and Correlates with Obesity and Insulin Resistance in Mouse (2010, methodology): “Levels of mRNA encoding TNF-a, a putative mediator of insulin resistance associated with obesity [15] and activation of an nuclear factor kappa-B (NF-kB) response element – enhanced Green Fluorescent Protein (EGFP) reporter transgene (NF-kB) were used as biomarkers of inflammation.”